Preferred Label : anakinra;
UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance;
CAS number : 9013DUQ28K;
Is substance : O;
UNII : 9013DUQ28K;
Origin ID : M0494869;
UMLS CUI : C0245109;
ATC code(s)
- Currated CISMeF NLP mapping
- Anakinra [International Nonproprietary Name]
- Exact mapping(s) to DCI
- Anakinra [International Nonproprietary Name]
- Related record
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
- Anakinra [International Nonproprietary Name]
https://www.has-sante.fr/jcms/p_3539129/fr/kineret-anakinra-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
anakinra
evaluation of the transparency committee
interleukin 1 receptor antagonist protein
injections, subcutaneous
biological therapy
chronic disease
---
https://ansm.sante.fr/tableau-marr/anakinra
2023
false
false
false
France
French
risk management
anakinra
guidelines for drug use
patient education handout
---
https://www.has-sante.fr/jcms/p_3329208/fr/kineret-anakinra-covid-19
2022
France
evaluation of the transparency committee
traction
Anakinra
kineret
indicators
interleukin 1 receptor antagonist protein
indication of
COVID-19
indicators and reagents
anakinra
---
https://ansm.sante.fr/actualites/suspension-des-inclusions-en-france-dans-les-essais-clinique-evaluant-lanakinra-dans-la-prise-en-charge-de-la-covid-19
2020
false
false
false
France
French
drug information
early termination of clinical trials
anakinra
anakinra
france
interleukin 1 receptor antagonist protein
pneumonia, viral
coronavirus infections
pandemics
COVID-19
---
https://www.has-sante.fr/jcms/p_3221969/fr/kineret-fievre-mediterraneenne-familiale-fmf
2020
false
false
false
France
treatment outcome
insurance, health, reimbursement
anakinra
familial mediterranean fever
injections, subcutaneous
guidelines for drug use
evaluation of the transparency committee
anakinra
interleukin 1 receptor antagonist protein
---
https://www.has-sante.fr/portail/jcms/c_2912136/fr/kineret
https://www.has-sante.fr/portail/jcms/c_2912136/fr/kineret-anakinra-immunosuppresseur
2019
false
true
false
false
France
injections, subcutaneous
treatment outcome
insurance, health, reimbursement
adult
adolescent
child
infant
Still's disease, Adult-Onset
arthritis, juvenile
antirheumatic agents
anakinra
interleukin 1 receptor antagonist protein
interleukin 1 receptor antagonist protein
guidelines for drug use
evaluation of the transparency committee
anakinra
interleukin 1 receptor antagonist protein
---
https://www.ansm.sante.fr/actualites/modification-des-conditions-de-prescription-et-delivrance-de-certaines-biotherapies-utilisees-dans-le-traitement-de-maladies-inflammatoires-chroniques-en-rhumatologie-gastroenterologie-dermatologie-ophtalmologie
2019
false
false
false
France
French
drug prescriptions
drug information
Adalimumab
Etanercept
golimumab
Certolizumab Pegol
anakinra
interleukin 1 receptor antagonist protein
antibodies, monoclonal
---
http://www.has-sante.fr/portail/jcms/c_1765197/fr/kineret
2014
false
France
French
adolescent
child
infant
cryopyrin-associated periodic syndromes
chronic infantile neurological, cutaneous, and articular syndrome
familial cold autoinflammatory syndrome
Muckle-Wells syndrome
treatment outcome
guidelines for drug use
insurance, health, reimbursement
drug therapy, combination
arthritis, rheumatoid
antirheumatic agents
injections, subcutaneous
interleukin 1 receptor antagonist protein
anakinra
evaluation of the transparency committee
anakinra
adult
methotrexate
---
http://www.has-sante.fr/portail/jcms/c_1749748/fr/kineret
http://www.has-sante.fr/portail/jcms/c_1701280/fr/kineret
http://www.has-sante.fr/portail/display.jsp?id=c_399561
http://www.has-sante.fr/portail/display.jsp?id=c_642557
2014
false
France
French
insurance, health, reimbursement
drug therapy, combination
arthritis, rheumatoid
antirheumatic agents
injections, subcutaneous
interleukin 1 receptor antagonist protein
anakinra
evaluation of the transparency committee
anakinra
adult
methotrexate
---
http://www.cri-net.com/fiches-pratiques-et-recommandations/prise-en-charge-pratique-des-patients-sous-anti-il1
2013
false
true
false
France
French
interleukin 1 receptor antagonist protein
interleukin 1 receptor antagonist protein
patient care management
continuity of patient care
guidelines for drug use
practice guideline
patients guideline
consensus
adolescent
child
adult
arthritis, rheumatoid
anakinra
anakinra
canakinumab
canakinumab
anakinra
canakinumab
Interleukin-1beta
cryopyrin-associated periodic syndromes
Juvenile-Onset still disease
Still's disease, Adult-Onset
rheumatoid arthritis, systemic juvenile
Idiopathic recurrent pericarditis
pericarditis
Castleman Disease
schnitzler syndrome
familial mediterranean fever
Erdheim-Chester disease
rare diseases
mevalonate kinase deficiency
periodic fever, familial, autosomal dominant
rilonacept
rilonacept
rilonacept
injections, subcutaneous
arthritis, juvenile
antibodies, monoclonal
antibodies, monoclonal
fever
hereditary autoinflammatory diseases
recombinant fusion proteins
recombinant fusion proteins
---
